CMMB · Chemomab Therapeutics Ltd.
$1.91
+0.01 (+0.53%)
At close · Aug 14
Market Cap
$14.07M
Shares
7.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-07-08 | — | |
| 6-K | 2026-06-02 | — | |
| 6-K | 2026-05-14 | — | |
| 6-K | 2026-05-06 | — | |
| 6-K | 2026-04-28 | — | |
| 20-F | 2026-03-23 | 2025-12-31 | |
| 6-K | 2026-03-20 | — | |
| 6-K | 2026-03-19 | — | |
| 6-K | 2025-11-21 | — | |
| 6-K | 2025-08-22 | — | |
| 6-K | 2025-08-14 | 2025-06-30 | |
| 6-K | 2025-07-25 | — | |
| 6-K | 2025-07-01 | — | |
| 6-K | 2025-05-27 | — | |
| 6-K | 2025-05-15 | — | |
| 6-K | 2025-04-15 | — | |
| 20-F | 2025-04-04 | 2024-12-31 | |
| 6-K | 2025-03-27 | — | |
| 6-K | 2025-03-20 | — | |
| 6-K | 2025-03-03 | — | |
| 6-K | 2025-02-19 | — | |
| 6-K | 2024-11-18 | — | |
| 6-K | 2024-11-14 | — | |
| 6-K | 2024-10-11 | — | |
| 6-K | 2024-08-21 | 2024-06-30 | |
| 6-K | 2024-07-25 | — | |
| 6-K | 2024-06-12 | — | |
| 6-K | 2024-05-09 | — | |
| 6-K | 2024-05-08 | — | |
| 6-K | 2024-05-03 | — | |
| 20-F | 2024-03-28 | 2023-12-31 | |
| 6-K | 2024-03-07 | — | |
| 6-K | 2024-01-03 | — | |
| 6-K | 2023-11-09 | — | |
| 6-K | 2023-08-14 | 2023-06-30 | |
| 6-K | 2023-08-08 | — | |
| 6-K | 2023-07-03 | — | |
| 8-K | 2023-06-16 | 2023-06-14 | |
| 8-K | 2023-06-05 | 2023-06-01 | |
| 8-K | 2023-05-11 | — | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| 10-K | 2023-03-20 | 2022-12-31 | |
| 8-K | 2023-02-21 | 2022-12-31 | |
| 8-K | 2023-02-21 | — | |
| 8-K | 2023-01-11 | — | |
| 8-K | 2023-01-03 | — | |
| 8-K/A | 2022-11-29 | 2022-11-14 | |
| 8-K | 2022-11-16 | — | |
| 8-K | 2022-11-14 | — | |
| 10-Q | 2022-11-10 | 2022-09-30 |
Showing 1–50 of 106 filings
Key facts
CIK
1534248
CUSIP
16385C203
13F (30d)
13 filings
13 filers
Visit website
Investor relations